Toxin, toxin-coregulated pili, and the toxR regulon are essential for Vibrio cholerae pathogenesis in humans

Isogenic mutant strains of V. cholerae O1 lacking elements of a genetic regulon controlled by toxR and implicated in virulence were tested in volunteers. A deletion mutation in ctxA, the gene encoding the A subunit of cholera toxin, markedly attenuated disease symptoms without affecting intestinal colonization. Deletion of toxR, the gene encoding the cholera toxin-positive regulatory protein resulted in a diminution in colonizing capacity. A deletion mutation in tcpA, encoding the major subunit of the toxin coregulated pilus (regulated by toxR), abolished the colonizing capacity of this strain. These results show for the first time the role of a specific pilus structure in colonization of the human intestine by V. cholerae O1 and exemplify the significance of a genetic regulon in pathogenesis.

[1]  J. Mekalanos,et al.  Safe, live Vibrio cholerae vaccines? , 1988, Vaccine.

[2]  M. Levine,et al.  Morphological studies on fimbriae expressed by Vibrio cholerae 01. , 1988, Microbial pathogenesis.

[3]  M. Levine,et al.  Volunteer studies of deletion mutants of Vibrio cholerae O1 prepared by recombinant techniques , 1988, Infection and immunity.

[4]  V. L. Miller,et al.  Use of phoA gene fusions to identify a pilus colonization factor coordinately regulated with cholera toxin. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[5]  M. Levine,et al.  Enzyme-linked immunosorbent assay to measure antibodies to purified heat-labile enterotoxins from human and porcine strains of Escherichia coli and to cholera toxin: application in serodiagnosis and seroepidemiology , 1985, Journal of clinical microbiology.

[6]  P. Manning,et al.  A common‐immunogenic Vibrio outer membrane protein , 1984 .

[7]  V. L. Miller,et al.  Synthesis of cholera toxin is positively regulated at the transcriptional level by toxR. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[8]  M. Levine,et al.  Evaluation of the human immune response to outer membrane proteins of Vibrio cholerae , 1984, Infection and immunity.

[9]  M. Levine,et al.  Evaluation in humans of attenuated Vibrio cholerae El Tor Ogawa strain Texas Star-SR as a live oral vaccine , 1984, Infection and immunity.

[10]  J. Mekalanos,et al.  Cholera toxin genes: nucleotide sequence, deletion analysis and vaccine development , 1983, Nature.

[11]  M. Levine,et al.  New knowledge on pathogenesis of bacterial enteric infections as applied to vaccine development. , 1983, Microbiological reviews.

[12]  S. Attridge,et al.  Prophylactic significance of the nonlipopolysaccharide antigens of Vibrio cholerae. , 1983, The Journal of infectious diseases.

[13]  P. Manning,et al.  Cell envelope proteins in Vibrio cholerae , 1982 .

[14]  R. Finkelstein,et al.  Characterization and distribution of the hemagglutinins produced by Vibrio cholerae , 1982, Infection and immunity.

[15]  M. Levine,et al.  Magnitude, kinetics, and duration of vibriocidal antibody responses in North Americans after ingestion of Vibrio cholerae. , 1982, The Journal of infectious diseases.

[16]  D. Chitnis,et al.  Role of somatic antigen of Vibrio cholerae in adhesion to intestinal mucosa. , 1982, Journal of medical microbiology.